Please assess the completion status of the following clinical trial:

Trial Title: Continuous Thetaburst Stimulation for the Treatment of Refractory Epilepsy - Safety, Feasibility and Proof-of-concept

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Refractory unifocal neocortical epilepsy with a well-defined ictal onset zone based on a standardized presurgical evaluation~* ≥ 4 seizures/month, for at least six months~* On a stable drug regimen for at least 2 months~* IQ \>70~* Reliable completion of a seizure diary by patient or caretakers~* Therapeutic compliance in the past~* Informed consent signed~Exclusion Criteria:~* Pregnancy, short-term birth wish or childbearing age without adequate birth control~* History of psychogenic non-epileptic seizures~* Intracranial metal hardware (excluding dental filling): surgical clips, shrapnell, electrodes under the stimulation area~* Presence of pacemaker, implantable cardioverter-defibrillator (ICD), permanent medication pumps, cochlear implants or deep brain stimulation (DBS)~Patients with a vagus nerve stimulator are not excluded, provided that adequate distance between the coil and the implanted material can be maintained.~As the short duration of the study will not interfere with an ongoing presurgical evaluation and/or its eventual conclusion, the patients in the course of the evaluation or awaiting surgery are also eligible for inclusion.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- continuous thetaburst stimulation (Type: EXPERIMENTAL): Transcranial magnetic stimulation over the epileptogenic focus using a cTBS stimulation protocol.

Based on this trial design, predict the completion outcome and termination type (if applicable).